Format

Send to

Choose Destination
JAMA. 1997 Aug 6;278(5):399-411.

Clinical recognition and management of patients exposed to biological warfare agents.

Author information

1
US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md, USA. USAMRIID@DETRICK.ARMY.MIL

Abstract

Concern regarding the use of biological agents--bacteria, viruses, or toxins--as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to violent disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Therefore, rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. We provide here a primer on 10 classic biological warfare agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.

PMID:
9244332
DOI:
10.1001/jama.278.5.399
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center